Stock comparison
ANI Pharmaceuticals
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ANIP
ANI Pharmaceuticals
Market cap
$1.88B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ANIP | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 53C | 69B | MTD |
| Benjamin Graham | 59D | 65B | MTD |
| Philip Fisher | 58C | 63C | MTD |
| Peter Lynch | 71C | 66B | ANIP |
| Joel Greenblatt | 44D | 68B | MTD |
| Charlie Munger | 47D | 74B | MTD |
| Terry Smith | 50D | 70B | MTD |
Side-by-side metrics
| Metric | ANIP | MTD |
|---|---|---|
| Market cap | $1.88B | $22.29B |
| P/E (TTM) | 18.5x | 25.3x |
| EV/EBIT | 22.4x | 21.6x |
| ROIC (TTM) | 8.17% | 36.09% |
| Gross margin | 65.94% | 57.79% |
| Net margin | 9.71% | 21.4% |
| Revenue CAGR 5y | 42.18% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.6x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ANIP leads on
- Revenue CAGR 5y42.18%vs 2.01%+95%
- P/E (TTM)18.5xvs 25.3x+27%
- Gross margin65.94%vs 57.79%+12%
MTD leads on
- Debt / Equity-vs 0.6x+101%
- Market cap$22.29Bvs $1.88B+92%
- ROIC (TTM)36.09%vs 8.17%+77%
- Net margin21.4%vs 9.71%+55%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.